Merck KGaA, Darmstadt, Germany
Frankfurter Straße 250
Darmstadt
64293
Germany
Tel: 49-6151-720
Fax: 49-6151-722000
Website: https://www.emdgroup.com/en
Email: service@emdgroup.com
646 articles about Merck KGaA, Darmstadt, Germany
-
Merck KGaA Halts Idera Pharmaceuticals, Inc. Cancer Drug Development Due to Safety Issues
7/7/2011
-
Merck KGaA Pulls Plug on Cladribine on FDA Feedback
6/23/2011
-
MDxHealth and Merck KGaA Extend Agreement for Use of MGMT Assay in Brain Cancer Clinical Trials
6/9/2011
-
Merck KGaA Eyes Job Cuts at Drug Unit Merck Serono
4/12/2011
-
Merck KGaA to Invest E13 Million in Israeli Biomed Incubator
3/31/2011
-
EMD Millipore Expands Product Portfolio With Merck KGaA Acquisition of Biotest AG’s Microbiology Business
3/22/2011
-
Merck KGaA Woos Investors Irked by ‘Bunker’ Culture, Dearth of New Drugs
3/10/2011
-
Merck KGaA's EMD Serono, Inc. (Billerica)'s MS Drug Cladribine Rejected by FDA
3/2/2011
-
Deal for Millipore Corporation Starting to Pay Off for Merck KGaA
2/23/2011
-
EU Declines To Approve Merck KGaA MS Pill
1/21/2011
-
Lead Discovery Center and Merck KGaA Enter Collaboration for the Discovery of Anti-Cancer Compounds
1/20/2011
-
Merck KGaA Buys Lab Equipment Maker Beijing Skywing
1/5/2011
-
Merck KGaA Sets up Indian Tech Center
1/4/2011
-
Recordati S.p.A In-Licenses Cardicor(R) in Italy From Merck KGaA
12/27/2010
-
Recordati In-Licenses Cardicor(R) in Italy From Merck KGaA
12/27/2010
-
Sanofi-Aventis (France) And Merck KGaA Sign Cancer Drug Deal
12/17/2010
-
Merck KGaA to Refrain From Big Deals For Now: Executive Says
12/7/2010
-
Merck KGaA Says FDA Extends Review of Multiple Sclerosis Pill, Caldribine in Setback for Novartis AG
11/29/2010
-
Evotec AG and Merck KGaA to Collaborate on Neurological Disease Target
11/23/2010
-
Gyros AB Platform Chosen by EMD Millipore in Expansion of Contract Service Offerings
11/15/2010